Celltrion, Top Search Ranking... Stock Price Up 7.41%
As of 10:31 AM on the 4th, Celltrion is trading at 377,000 KRW, up 7.41% from the previous day. This marks a 36.35% increase compared to November 10. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have a net purchase of 214,954 shares of Celltrion, and institutions have a net purchase of 2,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 116,472 shares, while foreigners and institutions have net sold 1,867 shares and 91,538 shares, respectively.
On December 1, Celltrion was a market topic for its "strong performance following the completion of Takeda Pharmaceutical's Asia-Pacific product asset acquisition."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- [Breaking] Blue House expresses "deep regret over Samsung negotiation breakdown... urges both sides to do their best for a final agreement"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
